Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Tongue Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Paranasal Sinus Neoplasms 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1

Interventions

Cisplatin 17Radiotherapy 11Cetuximab 11Surveys and Questionnaires 10pembrolizumab 9Biopsy 9Radiation 8Magnetic Resonance Spectroscopy 8Drug Therapy 8Surgical Procedures, Operative 7Radiotherapy, Intensity-Modulated 7Carboplatin 7X-Rays 6Specimen Handling 6Fluorouracil 6Celecoxib 6Standard of Care 5Paclitaxel 5Observation 5Sentinel Lymph Node Biopsy 4Interviews as Topic 4Chemoradiotherapy 41,2-diaminocyclohexaneplatinum II citrate 4Watchful Waiting 3Ultrasonography 3Taxes 3Practice Guidelines as Topic 3Positron Emission Tomography Computed Tomography 3Platinum 3Optical Imaging 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Mouth Neoplasms × Chemoprevention × Clear all
NCT01469429 2020-02-20

Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.

Ohio State University Comprehensive Cancer Center

Phase 1/2 Completed
70 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Paranasal Sinus Neoplasms, Salivary Gland Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡